Epidemiology

Incidence of TLS is unknown, as it has not been accurately assessed or documented in the majority of tumour types. It is more prevalent in haematological malignancies with high proliferating rates, tumour burden, and chemosensitivity (e.g., acute lymphocytic leukaemia and Burkitt's lymphoma).[1][2] Males and females of any age or ethnicity can be affected. Advanced age may increase the risk of developing TLS due to reduced glomerular filtration rate and the presence of comorbid conditions.

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer